[bluecalm]

Imagine it was discovered 5 years after the initial study that the medicine given during it was harmful and there are long term health consequences. The discovery was made by another team. Wouldn't you like to know?

Another example: a study for rare condition was conducted. No effective treatment was found. A few years later very promising treatment was discovered. Wouldn't you like to know, even if the original form didn't ask your permission?

[frereubu]

The easy way to remedy this is that all forms should ask for that permission explicitly, and many do. When doing an MSc in neuroscience, even though our research was about the contribution of early visual areas to reading tasks, we always asked permission to get in contact if we found anything problematic on structural MRI scans. If someone explicitly says no to that (which I can't remember happening - as you suggest, the vast majority of people would like to know) that's their choice.

Edit: What no-one has said here is whether the initial study did say that, and the original researchers were going against the wishes of the participants. Given how the researchers behaved that doesn't seem entirely unlikely.

[placer]

Probably the most extensive critical account of that 1973 Sobell study, and how the Pendery 1982 follow-up came to be published, is the book Alcoholism: A Review of its Characteristics, Etiology, Treatments, and Controversies by Irvine Maltzman. All quotes in this post come from that book.

One patient’s “attorney had complained to the Hospital about the treatment that he had received.” As I describe elsewhere in this thread, some of the patients ended up trying to sue the Sobells. So, no, the patients were not happy with the treatment they received.

The subjects had no problem being contacted for follow-up: “the patients contacted prior to the court injunction all expressed a willingness to cooperate and to be interviewed”

Indeed, a judge familiar with the medical privacy laws of that era (we’re talking the mid-to-late 1970s here) made a court decision that contacting the patients for follow-up was perfectly OK: “Judge Hauk concluded that on balance it was more important to determine how the patients were faring following treatment than any possible breach of confidentiality and invasion of privacy which were protected by their right to refuse to participate in the study.”

[bluecalm]

The takeaway is that it's not always possible to think about all the cases it's worth it to contact the person. At the end of the day it's one phone call or email. Mild inconvenience for potentially life changing chance or information. As long as it's a persona in a position like a doctor o researcher making a call I am happy to waste a minute of my life trusting their judgement.

I don't really like where the EU privacy laws are going. I want "try to be reasonable" option. If they are not I can always tell them to delete my contacts later.

[overscore]

EU data protection laws are reasonable. They allow for public health authorities to take all the steps you're suggesting, and they require companies which hold such information to make them available to those authorities. They do not allow researchers to transfer data to a third party to perform further research. Simple, clear, reasonable, and protective of the basic human rights of the study participants.

[s1artibartfast]

There are clear processes to go through for these situations. Usually, individuals can specify in the original contract if they are open to follow up.

>Another example: a study for rare condition was conducted. No effective treatment was found. A few years later very promising treatment was discovered. Wouldn't you like to know, even if the original form didn't ask your permission?

You are literally describing healthcare providers giving confidential medical information to third parties without consent. In no way should anyone but the patient be able to void or reinterpret the contract, their presumption of the patients wishes should never override those stated by the patient.

[bluecalm]

It's interesting how you are so convinced of it even though it's easy to come up with scenarios assuming about any ethical system where privacy concerns are less important.

I gave them something dangerous during the trial and they didn't agree to a follow up. I discovered they need treatment now or they will die (may happen with a poisoning for example). I am still contacting them and I surely hope you would too.

[s1artibartfast]

I think we might be making different assumptions. There are 3 options as I see it

1) If the contract signed by the patient is silent on the topic, and you have their information, you are free to contact them.

2) If the contract signed by the patient explicitly says you can not contact them for this reason, then I think it clearly unethical to do so.

3) If the contract is ambiguous, or the intent is unclear, then it is a judgement call.

I am talking about #2 and I think you are talking about #1 & 3.

There are valid reasons why people would want to select #2, and if they do, their wishes should be respected.

[overscore]

In the EU, those cases would be covered by the lawful basis of being in the vital interest of data subject. However, that would only cover that particular reason for processing, and in the scenarios above would be handled by a public health authority. It would not allow personal data to transfer to a third party for the purpose of continued research.